{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:39:06Z","timestamp":1793126346533,"version":"4.5.0"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T00:00:00Z","timestamp":1507593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001775","name":"University of Technology Sydney","doi-asserted-by":"publisher","award":["Doctoral Scholarship"],"award-info":[{"award-number":["Doctoral Scholarship"]}],"id":[{"id":"10.13039\/501100001775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["Health Services Research Grant ID 455366"],"award-info":[{"award-number":["Health Services Research Grant ID 455366"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001171","name":"Cancer Institute NSW","doi-asserted-by":"publisher","award":["Career Development Fellowship ID 12\/CDF\/2-25"],"award-info":[{"award-number":["Career Development Fellowship ID 12\/CDF\/2-25"]}],"id":[{"id":"10.13039\/501100001171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0184360","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T13:25:52Z","timestamp":1507641952000},"page":"e0184360","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":438,"title":["Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5690-9542","authenticated-orcid":true,"given":"Alison","family":"Pearce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalie","family":"Viney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sallie-Anne","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Haywood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,10,10]]},"reference":[{"key":"ref1","article-title":"<italic>Health technologies and decision making<\/italic>","year":"2005"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc1529","article-title":"Timeline: Chemotherapy and the war on cancer","volume":"5","author":"B.A Chabner","year":"2005","journal-title":"Nature Reviews Cancer"},{"key":"ref3","unstructured":"American Cancer Society. <italic>After diagnosis<\/italic>: <italic>A guide for patients and families<\/italic>. 2012 [cited 2016 May 03]; <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cancer.org\/acs\/groups\/cid\/documents\/webcontent\/002813-pdf.pdf\" xlink:type=\"simple\">http:\/\/www.cancer.org\/acs\/groups\/cid\/documents\/webcontent\/002813-pdf.pdf<\/ext-link>"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cncr.10630","article-title":"Changing patient perceptions of the side effects of cancer chemotherapy","volume":"95","author":"N. Carelle","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","article-title":"On the receiving end: patient perception of the side-effects of cancer chemotherapy","volume":"19","author":"A. Coates","year":"1983","journal-title":"European Journal of Cancer and Clinical Oncology"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/bjc.1997.507","article-title":"Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists","volume":"76","author":"M. de Boer-Dennert","year":"1997","journal-title":"British Journal of Cancer"},{"key":"ref7","unstructured":"Cancer Institute NSW. EviQ: Cancer Treatments Online. [cited 2016 May 03]; EviQ version 1.4.0:[<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.eviq.org.au\/Home.aspx\" xlink:type=\"simple\">https:\/\/www.eviq.org.au\/Home.aspx<\/ext-link>."},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1056\/NEJM198101013040103","article-title":"Dose-Response Effect of Adjuvant Chemotherapy in Breast Cancer","volume":"304","author":"G Bonadonna","year":"1981","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"ref9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199504063321401","article-title":"Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up","volume":"332","author":"G. Bonadonna","year":"1995","journal-title":"New England Journal of Medicine"},{"issue":"18","key":"ref10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199405053301801","article-title":"Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma","volume":"330","author":"W.C. Wood","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"ref11","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.breast.2008.05.006","article-title":"Dose variation and regimen modification of adjuvant chemotherapy in daily practice affect survival of stage I\u2013II and operable stage III Taiwanese breast cancer patients","volume":"17","author":"S.H. Kuo","year":"2008","journal-title":"Breast"},{"issue":"9453","key":"ref12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0140-6736(04)17670-8","article-title":"External validity of randomised controlled trials: &quot;to whom do the results of this trial apply?&quot;","volume":"365","author":"P.M. Rothwell","year":"2005","journal-title":"Lancet"},{"issue":"19","key":"ref13","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1001\/archinternmed.2009.306","article-title":"Reporting of safety results in published reports of randomized controlled trials","volume":"169","author":"I. Pitrou","year":"2009","journal-title":"Archives of Internal Medicine"},{"issue":"24","key":"ref14","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1200\/JCO.2005.05.3959","article-title":"Adverse event reporting in publications compared with sponsor database for cancer clinical trials","volume":"24","author":"O Scharf","year":"2006","journal-title":"Journal of clinical oncology"},{"issue":"8","key":"ref15","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anticancer treatment: Agreement between patient and physician reporting in three randomised trials","volume":"33","author":"M Di Maio","year":"2015","journal-title":"Journal of Clinical oncology"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","article-title":"Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire based study","volume":"7","author":"E. Basch","year":"2006","journal-title":"Lancet Oncology"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1524-4733.2007.00186.x","article-title":"Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report","volume":"10","author":"L.P. Garrison Jr.","year":"2007","journal-title":"Value in health"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/annonc\/mdq683","article-title":"Long-term toxic effects of adjuvant chemotherapy in breast cancer","volume":"22","author":"H.A. Azim","year":"2011","journal-title":"Annals of Oncology"},{"issue":"17","key":"ref19","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1002\/cncr.27422","article-title":"Comparison of adverse events during 5-fluorouracil versus 5-fluorouracil\/oxaliplatin adjuvant chemotherapy for stage III colon cancer","volume":"118","author":"H.K. Sanoff","year":"2012","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"d4013","DOI":"10.1136\/bmj.d4013","article-title":"Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study","volume":"343","author":"J.P. Wisnivesky","year":"2011","journal-title":"BMJ"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1001\/jama.2010.272","article-title":"Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer","volume":"303","author":"K.l. Kahn","year":"2010","journal-title":"JAMA"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/annonc\/mdh110","article-title":"The impact of delayed chemotherapy-induced nausea and vomiting on patients, health resource utilization and costs in German cancer centers","volume":"15","author":"A. Ihbe-Heffinger","year":"2004","journal-title":"Annals of oncology"},{"issue":"24","key":"ref23","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1200\/JCO.2002.05.088","article-title":"Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer","volume":"20","author":"X.L. Du","year":"2002","journal-title":"Journal of clinical oncology"},{"issue":"1","key":"ref24","first-page":"84","article-title":"Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study","volume":"91","author":"J. Lopez-Jimenez","year":"2006","journal-title":"Haematologica"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00520-007-0380-2","article-title":"Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the US","volume":"16","author":"D.H. Henry","year":"2008","journal-title":"Supportive Care in Cancer"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/ajco.12354","article-title":"The cost of cancer care for patients undergoing chemotherapy\u2014the Elements of Cancer Care study","volume":"11","author":"R. Ward","year":"2015","journal-title":"Asia-Pacific Journal of Clinical Oncology"},{"key":"ref27","unstructured":"National Cancer Institute, Common Terminology Criteria for Adverse Events v4.03. 2010, National Institute of Health."},{"key":"ref28","unstructured":"Australian Bureau of Statistics. Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2011, \u2018Table 1: Postal area (POA) SEIFA Summary, 2011\u2019, datacube: Excel spreadsheet \u2018Postal Area, Indexes, SEIFA 2011\u2019, cat. no. 2033.0.55.001, <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/Lookup\/2033.0.55.001Main+Features12011?OpenDocument\" xlink:type=\"simple\">http:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/Lookup\/2033.0.55.001Main+Features12011?OpenDocument<\/ext-link>"},{"issue":"27","key":"ref29","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1200\/JCO.2006.05.6382","article-title":"Delayed nausea and vomiting continue to reduce patients&apos; quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment","volume":"24","author":"B. Bloechl-Daum","year":"2006","journal-title":"J Clin Oncol"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-144-4-200602210-00007","article-title":"Brief communication: Better ways to question patients about adverse medical events: a randomized, controlled trial","volume":"144","author":"S. Bent","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"17","key":"ref31","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.2004.03.025","article-title":"How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30","volume":"22","author":"E.K. Fromme","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"dju244","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute\u2019s patient-reported outcomes version of the comon terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"E. Basch","year":"2014","journal-title":"Journal of the National Cancer Insitute"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1586\/14737167.2015.990888","article-title":"Can administrative data be used to measure chemotherapy side effects?","volume":"15","author":"A. Pearce","year":"2015","journal-title":"Expert Reviews of Pharmacoeconomics and Outcomes Research"},{"issue":"2 Suppl","key":"ref34","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1177\/0272989X98018002S03","article-title":"Experimental versus observational data in the economic evaluation of pharmaceuticals","volume":"18","author":"M.F. Drummond","year":"1998","journal-title":"Medical Decision Making"},{"issue":"5","key":"ref35","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pmrj.2010.03.022","article-title":"Fatigue and fatigability in older adults","volume":"2","author":"B.A. Eldadah","year":"2010","journal-title":"PM&R"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.bpg.2009.09.001","article-title":"Constipation in old age","volume":"23","author":"P Gallagher","year":"2009","journal-title":"Best Practice and Research Clinical Gastroenterology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0184360","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T09:43:03Z","timestamp":1540201383000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0184360"}},"subtitle":[],"editor":[{"given":"Apar Kishor","family":"Ganti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,10]]},"references-count":36,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0184360","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,10]]}}}